Aminocandin

File:Aminocandin.svg

Aminocandin is an echinocandin-class antifungal drug. It is used primarily in the treatment of fungal infections, particularly those caused by Candida and Aspergillus species. Aminocandin works by inhibiting the synthesis of β-(1,3)-D-glucan, an essential component of the fungal cell wall, thereby leading to cell lysis and death.

Mechanism of Action

Aminocandin targets the enzyme β-(1,3)-D-glucan synthase, which is crucial for the formation of β-(1,3)-D-glucan in the fungal cell wall. By inhibiting this enzyme, aminocandin disrupts the integrity of the cell wall, causing osmotic instability and ultimately leading to cell death.

Clinical Uses

Aminocandin is primarily used to treat:

• Invasive candidiasis
• Esophageal candidiasis
• Invasive aspergillosis
• Febrile neutropenia in patients suspected of having fungal infections

Pharmacokinetics

Aminocandin is administered intravenously due to its poor oral bioavailability. It has a long half-life, allowing for once-daily dosing. The drug is metabolized in the liver and excreted primarily in the feces.

Side Effects

Common side effects of aminocandin include:

• Nausea
• Vomiting
• Diarrhea
• Headache
• Rash

Serious side effects may include:

• Hepatotoxicity
• Hypersensitivity reactions
• Anaphylaxis

History

Aminocandin was developed as part of the ongoing search for effective antifungal agents with fewer side effects and broader activity against resistant fungal strains. It was approved for medical use in year.

See Also

• Echinocandin
• Antifungal
• Candida
• Aspergillus
• β-(1,3)-D-glucan